![]() |
NeoPharm Presents The Phase II Data Of Liposome-Entrapped Paclitaxel (LEP) In Patient
NeoPharm, Inc. (Other OTC: NEOL.PK) announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India...
More... |
| All times are GMT -7. The time now is 11:16 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021